secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2026-05-29T21:10:15+00:00
Accession:  0001493152-26-026431
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma shareholders elect directors and ratify Crowe LLP as auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- All nine director nominees (including Ilya Rachman, Gabriel Morris, Jason Hsu) elected with over 35M votes each; broker non-votes ~6.4M.
- Ratification of Crowe LLP as independent auditor for FY 2026 passed: 42.3M For, 11.5K Against, 18.4K Abstentions.
- Meeting held May 22, 2026; results reported on May 29, 2026; overwhelming support for all proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315226026431/0001493152-26-026431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315226026431/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer